Iris E. Beldhuis

826 total citations
29 papers, 468 citations indexed

About

Iris E. Beldhuis is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Iris E. Beldhuis has authored 29 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Iris E. Beldhuis's work include Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (10 papers) and Potassium and Related Disorders (9 papers). Iris E. Beldhuis is often cited by papers focused on Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (10 papers) and Potassium and Related Disorders (9 papers). Iris E. Beldhuis collaborates with scholars based in Netherlands, United States and Canada. Iris E. Beldhuis's co-authors include Kevin Damman, Adriaan A. Voors, Jozine M. ter Maaten, Scott D. Solomon, John J.V. McMurray, Brian Claggett, Marc A. Pfeffer, Akshay S. Desai, Koen W. Streng and Peter van der Meer and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Iris E. Beldhuis

26 papers receiving 465 citations

Peers

Countries citing papers authored by Iris E. Beldhuis

Since Specialization

Citations

This map shows the geographic impact of Iris E. Beldhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris E. Beldhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris E. Beldhuis more than expected).

Fields of papers citing papers by Iris E. Beldhuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris E. Beldhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris E. Beldhuis. The network helps show where Iris E. Beldhuis may publish in the future.

Co-authorship network of co-authors of Iris E. Beldhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Iris E. Beldhuis. A scholar is included among the top collaborators of Iris E. Beldhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris E. Beldhuis. Iris E. Beldhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction 2025 ·JACC Heart Failure ·Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt, Tor Biering‐Sørensen, Akshay S. Desai, Eldrin F. Lewis, Pardeep S. Jhund, Finnian R. Mc Causland, Inder S. Anand, Marc A. Pfeffer, Bertram Pitt, (unknown), Michael R. Zile, John J.V. McMurray, Scott Solomon, Muthiah Vaduganathan	2
2	Outpatient Loop Diuretic Use and the Effect of Natriuresis-Guided Diuretic Therapy: A Prespecified Sub-Analysis of the PUSH-AHF Study 2025 ·European Journal of Heart Failure ·(unknown), Iris E. Beldhuis, (unknown), Dirk J. van Veldhuisen, (unknown), Wybe Nieuwland, Jan A. Krikken, Peter van der Meer, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten	0
3	Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction 2024 ·JACC Heart Failure ·Brendon L. Neuen, Muthiah Vaduganathan, Brian Claggett, Iris E. Beldhuis, Peder L. Myhre, Akshay S. Desai, Hicham Skali, Finnian R. Mc Causland, Martina M. McGrath, Inder S. Anand, Michael R. Zile, Marc A. Pfeffer, John J.V. McMurray, Scott D. Solomon	8
4	Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes 2024 ·Journal of the American College of Cardiology ·Brendon L. Neuen, John W. Ostrominski, Brian Claggett, Iris E. Beldhuis, Safia Chatur, Finnian R. McCausland, Sunil V. Badve, Clare Arnott, Hiddo J.L. Heerspink, Min Jun, Michael O. Falster, Juliana de Oliveira Costa, Carol A. Pollock, Meg Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Scott D. Solomon, Muthiah Vaduganathan	5
5	Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2 2024 ·JACC Heart Failure ·Safia Chatur, Iris E. Beldhuis, Brian Claggett, Finnian R. McCausland, Brendon L. Neuen, Akshay S. Desai, Jean L. Rouleau, Michael R. Zile, Milton Packer, Marc A. Pfeffer, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan	5
6	Renal Function and Natriuresis-Guided Diuretic Therapy – A Pre-Specified Analysis from the PUSH-AHF Trial 2024 ·European Journal of Heart Failure ·Kevin Damman, Iris E. Beldhuis, Peter van der Meer, Jan A. Krikken, (unknown), Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Jozine M. ter Maaten	8
7	Association of fibrotic markers with diastolic function after STEMI 2024 ·Scientific Reports ·(unknown), Wouter C. Meijers, Iris E. Beldhuis, Hilde E. Groot, Erik Lipšic, Dirk J. van Veldhuisen, Adriaan A. Voors, Iwan C.C. van der Horst, Rudolf A. de Boer, Pim van der Harst	2
8	Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial 2024 ·European Heart Journal ·Brendon L. Neuen, John W. Ostrominski, Brian Claggett, Iris E. Beldhuis, Safia Chatur, Clare Arnott, Hiddo J.L. Heerspink, Carol A. Pollock, Meg Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Scott D. Solomon, (unknown)	0
9	End-organ Protective Effect of Serelaxin in Patients Hospitalized for Heart Failure: Results of the Biomarker Substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2) 2024 ·European Journal of Heart Failure ·Adriaan A. Voors, Marco Metra, Douwe Postmus, Barry Greenberg, Gad Cotter, Beth A. Davison, Iris E. Beldhuis, G. Michael Felker, (unknown), Peter S. Pang, Piotr Ponikowski, Claudio Gimpelewicz, John R. Teerlink	1
10	Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure 2024 ·Journal of the American College of Cardiology ·Safia Chatur, Brendon L. Neuen, Brian Claggett, Iris E. Beldhuis, Finnian R. Mc Causland, Akshay S. Desai, Jean L. Rouleau, Michael R. Zile, Martin Lefkowitz, Milton Packer, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan	7
11	Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials 2024 ·Circulation ·Jawad H. Butt, John J.V. McMurray, Brian Claggett, Pardeep S. Jhund, Brendon L. Neuen, Finnian R. McCausland, Akshay S. Desai, Carolyn S.P. Lam, Bertram Pitt, Marc A. Pfeffer, Milton Packer, Iris E. Beldhuis, Adriaan A. Voors, Faı̈ez Zannad, (unknown), Scott D. Solomon, Muthiah Vaduganathan	3
12	Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure 2024 ·JACC Heart Failure ·Matteo Pagnesi, (unknown), Jozine M. ter Maaten, Iris E. Beldhuis, Gad Cotter, Beth A. Davison, Niels Jongs, G. Michael Felker, (unknown), Barry Greenberg, Peter S. Pang, Piotr Ponikowski, Carlo Lombardi, Marianna Adamo, Thomas Severin, Claudio Gimpelewicz, Adriaan A. Voors, John R. Teerlink, Marco Metra	4
13	Natriuretic peptides, kidney function and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: pooled data from the I-PRESERVE, TOPCAT, PARAGON and DELIVER trials 2024 ·European Heart Journal ·Brendon L. Neuen, Muthiah Vaduganathan, Brian Claggett, Iris E. Beldhuis, Peder L. Myhre, Akshay S. Desai, Hicham Skali, Finnian R. Mc Causland, Mary H. McGrath, Inder S. Anand, Michael R. Zile, Marc A. Pfeffer, John J.V. McMurray, Scott Solomon	0
14	Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 Trial 2023 ·European Journal of Heart Failure ·Matteo Pagnesi, Marianna Adamo, Jozine M. ter Maaten, Iris E. Beldhuis, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Barry Greenberg, Peter S. Pang, Piotr Ponikowski, Iziah E Sama, Thomas Severin, Claudio Gimpelewicz, Adriaan A. Voors, John R. Teerlink, Marco Metra	9
15	Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure 2023 ·Clinical Research in Cardiology ·Iris E. Beldhuis, Jozine M. ter Maaten, Sylwia M. Figarska, Kevin Damman, Peter S. Pang, Barry Greenberg, Beth A. Davison, Gad Cotter, Thomas Severin, Claudio Gimpelewicz, G. Michael Felker, Gerasimos Filippatos, John R. Teerlink, Marco Metra, Adriaan A. Voors	3
16	Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial 2023 ·Nature Medicine ·Jozine M. ter Maaten, Iris E. Beldhuis, Peter van der Meer, Jan A. Krikken, Douwe Postmus, (unknown), Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Kevin Damman	65
17	Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure ( PUSH‐AHF ) trial 2021 ·European Journal of Heart Failure ·Jozine M. ter Maaten, Iris E. Beldhuis, Peter van der Meer, Jan A. Krikken, (unknown), Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Kevin Damman	31
18	Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function 2021 ·Journal of the American College of Cardiology ·Iris E. Beldhuis, Peder L. Myhre, Michael R. Bristow, Brian Claggett, Kevin Damman, James C. Fang, Jerome L. Fleg, Sonja M. McKinlay, Eldrin F. Lewis, Eileen O’Meara, Bertram Pitt, Sanjiv J. Shah, Orly Vardeny, Adriaan A. Voors, Marc A. Pfeffer, Scott D. Solomon, Akshay S. Desai	31
19	Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure 2019 ·JACC Heart Failure ·Orly Vardeny, Brian Claggett, Muthiah Vaduganathan, Iris E. Beldhuis, Jean L. Rouleau, Eileen O’Meara, Inder S. Anand, Sanjiv J. Shah, Nancy K. Sweitzer, James C. Fang, Akshay S. Desai, Eldrin F. Lewis, Bertram Pitt, Marc A. Pfeffer, Scott D. Solomon	8
20	Trajectories of Changes in Renal Function in Patients with Acute Heart Failure 2019 ·Journal of Cardiac Failure ·Iris E. Beldhuis, Koen W. Streng, Peter van der Meer, Jozine M. ter Maaten, Christopher M. O’Connor, Marco Metra, Howard C. Dittrich, Piotr Ponikowski, Gad Cotter, John G.F. Cleland, Beth A. Davison, Michael M. Givertz, John R. Teerlink, Daniel M. Bloomfield, Adriaan A. Voors, Kevin Damman	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact